Shalby

Shalby Net Margin

The Net Profit Margin of Shalby (SHALBY.NS) as of Oct 21, 2026 is 3.28 %. In the previous year, Net Profit Margin was 0.57 % — a change of 472.24% (higher).

Net Margin

3.28 %

YoY

472.24%

Last updated:

Net Profit Margin of Shalby is 2026 3.28 % . Net Profit Margin of Shalby was 2025 0.57 % . It decreases by 472.24% higher compared to the previous year.

For Shalby, the net margin of 3.3% is down versus 7.7% a few years ago.

The Shalby Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2019
6.87 INR
Jan 1, 2020
5.67 INR
Jan 1, 2021
9.84 INR
Jan 1, 2022
7.74 INR
Jan 1, 2023
8.41 INR
Jan 1, 2024
9.00 INR
Jan 1, 2025
0.57 INR
Jan 1, 2026
3.28 INR
The Shalby Net Margin history
YEARNet MarginYoY
3.28 %+472.24%
0.57 %-93.64%
9.00 %+7.05%
8.41 %+8.61%
7.74 %-21.29%
9.84 %+73.64%
5.67 %-17.50%
6.87 %-38.67%
11.20 %-41.75%
19.23 %+48.57%
12.94 %+38.51%
9.34 %-38.02%
15.08 %+19,741.95%
0.08 %-46.68%
0.14 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Shalby Stock analysis

What does Shalby do? Shalby Ltd operates hospitals and outpatient clinics in Ahmedabad, Gujarat, with 2,678 full-time employees. The company generates revenue through its Healthcare Services segment, which includes managing hospitals and medical diagnostic services, and its Manufacturing segment focused on producing implants. Key specialties driving demand include joint replacement surgery, critical care, spine surgery, neurology, cardiology, and organ transplants such as kidney and liver procedures. Patients seeking specialized treatments, including ortho-oncology, IVF, and bariatric surgery, form the primary customer base for its healthcare services. The firm's manufacturing division produces medical implants, serving hospitals and clinics under its own brand. Services like homecare, dental cosmetics, and ophthalmology cater to a diverse patient demographic. Revenue streams are derived from both direct patient care and the supply of implants to its own facilities, with no external brands or partnerships mentioned in the business description. Shalby Ltd's business model relies on integrated healthcare delivery across multiple specialties, combining hospital management, diagnostic services, and implant manufacturing. The company's focus on high-demand medical procedures ensures consistent patient flow, while its manufacturing segment supports internal operations without external sales. All services are provided within its owned facilities, emphasizing a vertically integrated approach to healthcare delivery. Shalby is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Shalby stock

Net Profit Margin of Shalby is 3.28 % in 2026.

Net Profit Margin of Shalby changed from 0.57 % to 3.28 %, representing a 472.24% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Shalby since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Shalby with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Shalby

All Key Metrics — Shalby